This inventor holds 42 USPTO granted patents and 4 published patent applications and 7 EPO patents, primarily in Chemical Compounds. Top assignees: Tdk Corporation, Seikagaku Corporation, Sony Corporation. Active years: 1984-2017.
Location History:
- Kawaguchi, JP (1986)
- Kanagawa, JP (1988)
- Tama, JP (1992)
- Sagamihara, JP (2008 - 2012)
- Higashiyamato, JP (2013 - 2015)
- Minato-ku, JP (2016)
- Tokyo, JP (1984 - 2017)
Company Filing History:
10 out of 8,232 
7 out of 194 
7 out of 58,144 
Years Active: 1984-2017
Areas of Expertise:
Title: Nobuo Kobayashi: Innovator in Pharmaceutical Composition
Introduction
Nobuo Kobayashi is a distinguished inventor based in Tokyo, Japan, renowned for his contributions to pharmaceutical innovations. With a remarkable portfolio comprising 42 patents, Kobayashi has significantly impacted the field of medicine, specifically in the treatment of diseases related to bone resorption.
Latest Patents
Kobayashi's latest patents include the development of an α-oxoacyl amino-caprolactam derivative. The primary purpose of this invention is to provide a pharmaceutical composition beneficial in treating diseases caused by increased bone resorption. Notably, this composition is designed to avoid serious side effects, even when used concurrently with other medications. The innovation involves a unique α-oxoacyl amino-caprolactam derivative represented by a specific formula, which includes structural components defined by specific chemical groups. Additionally, Kobayashi has developed another related patent on the α-oxoacyl amino-caprolactam, which serves as a bone resorption inhibitor, further demonstrating his commitment to advancing medical science.
Career Highlights
Throughout his career, Nobuo Kobayashi has been associated with prominent corporations including TDK Corporation and Sony Corporation. His experiences in these leading technology firms have equipped him with the expertise and resources necessary to propel his innovative research endeavors.
Collaborations
Kobayashi has worked alongside notable colleagues such as Tsuneo Koji and Hisatomo Kunii. Their collaborations have further enhanced the scope of research and innovation within the pharmaceutical field, bringing together a wealth of knowledge and experience.
Conclusion
In conclusion, Nobuo Kobayashi stands out as a key figure in the realm of pharmaceutical inventions, particularly in his work focused on treating bone resorption-related diseases. His extensive patent portfolio underscores his capability as an inventor and his commitment to enhancing health through innovation. Through his collaborations and career experiences, Kobayashi continues to influence the pharmaceutical landscape, making notable strides toward better treatment options.